|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xu J, Zheng H, Yuan S, Zhou B, Zhao W, Pan
Y and Qi D: Overexpression of ANLN in lung adenocarcinoma is
associated with metastasis. Thorac Cancer. 10:1702–1709. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tsutsui T, Yamaki H, Kumagai T, Omori C,
Kobayashi H, Kakizaki Y and Miyashita Y: Small cell lung cancer
with thyroid gland oligometastasis: A case report. Thorac Cancer.
12:387–390. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Denisenko TV, Budkevich IN and Zhivotovsky
B: Cell death-based treatment of lung adenocarcinoma. Cell Death
Dis. 9:1172018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Eberle A, Jansen L, Castro F, Krilaviciute
A, Luttmann S, Emrich K, Holleczek B, Nennecke A, Katalinic A and
Brenner H; GEKID Survival Working Group, : Lung cancer survival in
Germany: A population-based analysis of 132,612 lung cancer
patients. Lung Cancer. 90:528–533. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Qu S, Yang X, Li X, Wang J, Gao Y, Shang
R, Sun W, Dou K and Li H: Circular RNA: A new star of noncoding
RNAs. Cancer Lett. 365:141–148. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu YY, Zhang LY and Du WZ: Circular RNA
circ-PVT1 contributes to paclitaxel resistance of gastric cancer
cells through the regulation of ZEB1 expression by sponging
miR-124-3p. Biosci Rep. 39:BSR201930452019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Momen-Heravi F and Bala S: Emerging role
of non-coding RNA in oral cancer. Cell Signal. 42:134–143. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sun X, Luo L and Gao Y: Circular RNA PVT1
enhances cell proliferation but inhibits apoptosis through sponging
microRNA-149 in epithelial ovarian cancer. J Obstet Gynaecol Res.
46:625–635. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Panda AC: Circular RNAs act as miRNA
sponges. Adv Exp Med Biol. 1087:67–79. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhu W, He J, Chen D, Zhang B, Xu L, Ma H,
Liu X, Zhang Y and Le H: Expression of miR-29c, miR-93, and miR-429
as potential biomarkers for detection of early stage non-small lung
cancer. PLoS One. 9:e877802014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xiao H, Zhu Q and Zhou J: Long non-coding
RNA MALAT1 interaction with miR-429 regulates the proliferation and
EMT of lung adenocarcinoma cells through RhoA. Int J Clin Exp
Pathol. 12:419–430. 2019.PubMed/NCBI
|
|
13
|
Zou J, Liu L, Wang Q, Yin F, Yang Z, Zhang
W and Li L: Downregulation of miR-429 contributes to the
development of drug resistance in epithelial ovarian cancer by
targeting ZEB1. Am J Transl Res. 9:1357–1368. 2017.PubMed/NCBI
|
|
14
|
Wang L, Mezencev R, Svajdler M, Benigno BB
and McDonald JF: Ectopic over-expression of miR-429 induces
mesenchymal-to-epithelial transition (MET) and increased drug
sensitivity in metastasizing ovarian cancer cells. Gynecol Oncol.
134:96–103. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sun H, Wang H and Wang X, Aoki Y and Wang
X, Yang Y, Cheng X, Wang Z and Wang X: Aurora-A/SOX8/FOXK1
signaling axis promotes chemoresistance via suppression of cell
senescence and induction of glucose metabolism in ovarian cancer
organoids and cells. Theranostics. 10:6928–6945. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Long Z and Wang Y: miR-195-5p suppresses
lung cancer cell proliferation, migration, and invasion via FOXK1.
Technol Cancer Res Treat. 19:15330338209225872020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang L, Liang Y, Mao Q, Xia W, Chen B,
Shen H, Xu L, Jiang F and Dong G: Circular RNA circCRIM1 inhibits
invasion and metastasis in lung adenocarcinoma through the microRNA
(miR)-182/miR-93-leukemia inhibitory factor receptor pathway.
Cancer Sci. 110:2960–2972. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Maass PG, Glazar P, Memczak S, Dittmar G,
Hollfinger I, Schreyer L, Sauer AV, Toka O, Aiuti A, Luft FC and
Rajewsky N: A map of human circular RNAs in clinically relevant
tissues. J Mol Med (Berl). 95:1179–1189. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou R, Wu Y, Wang W, Su W, Liu Y, Wang Y,
Fan C, Li X, Li G, Li Y, et al: Circular RNAs (circRNAs) in cancer.
Cancer Lett. 425:134–142. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wan L, Zhang L, Fan K, Cheng ZX, Sun QC
and Wang JJ: Circular RNA-ITCH suppresses lung cancer proliferation
via inhibiting the Wnt/β-Catenin pathway. Biomed Res Int.
2016:15794902016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen X, Mao R, Su W, Yang X, Geng Q, Guo
C, Wang Z, Wang J, Kresty LA, Beer DG, et al: Circular RNA
circHIPK3 modulates autophagy via MIR124-3p-STAT3-PRKAA/AMPKalpha
signaling in STK11 mutant lung cancer. Autophagy. 16:659–671. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ma X, Yang X, Bao W, Li S, Liang S, Sun Y,
Zhao Y, Wang J and Zhao C: Circular RNA circMAN2B2 facilitates lung
cancer cell proliferation and invasion via miR-1275/FOXK1 axis.
Biochem Biophys Res Commun. 498:1009–1015. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu C, Hu W, Li LL, Wang YX, Zhou Q, Zhang
F, Song-Yang YY, Zhu W, Sun CC and Li DJ: Roles of miR-200 family
members in lung cancer: More than tumor suppressors. Future Oncol.
14:2875–2886. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xiao P, Liu W and Zhou H: miR-429 promotes
the proliferation of non-small cell lung cancer cells via targeting
DLC-1. Oncol Lett. 12:2163–2168. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kulcheski FR, Christoff AP and Margis R:
Circular RNAs are miRNA sponges and can be used as a new class of
biomarker. J Biotechnol. 238:42–51. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen D, Ma W, Ke Z and Xie F: CircRNA
hsa_circ_100395 regulates miR-1228/TCF21 pathway to inhibit lung
cancer progression. Cell Cycle. 17:2080–2090. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Qu D, Yan B, Xin R and Ma T: A novel
circular RNA hsa_circ_0020123 exerts oncogenic properties through
suppression of miR-144 in non-small cell lung cancer. Am J Cancer
Res. 8:1387–1402. 2018.PubMed/NCBI
|
|
29
|
Chen D, Wang K, Li X, Jiang M, Ni L, Xu B,
Chu Y, Wang W, Wang H, Kang H, et al: FOXK1 plays an oncogenic role
in the development of esophageal cancer. Biochem Biophys Res
Commun. 494:88–94. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li L, Gong M, Zhao Y, Zhao X and Li Q:
FOXK1 facilitates cell proliferation through regulating the
expression of p21, and promotes metastasis in ovarian cancer.
Oncotarget. 8:70441–70451. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wu M, Wang J, Tang W, Zhan X, Li Y, Peng
Y, Huang X, Bai Y, Zhao J, Li A, et al: FOXK1 interaction with FHL2
promotes proliferation, invasion and metastasis in colorectal
cancer. Oncogenesis. 5:e2712016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kun-Peng Z, Xiao-Long M and Chun-Lin Z:
Overexpressed circPVT1, a potential new circular RNA biomarker,
contributes to doxorubicin and cisplatin resistance of osteosarcoma
cells by regulating ABCB1. Int J Biol Sci. 14:321–330. 2018.
View Article : Google Scholar : PubMed/NCBI
|
